Intra-Cellular Therapies Inc (NASDAQ:ITCI)

19.46
Delayed Data
As of Feb 23
 +0.30 / +1.57%
Today’s Change
7.85
Today|||52-Week Range
22.67
+34.39%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close19.16
Today’s open19.34
Day’s range18.65 - 19.58
Volume362,942
Average volume (3 months)444,878
Market cap$1.0B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+7.56%
Earnings growth (this year)+22.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+261.96%
P/E ratioNM
Price/Sales1,973.06
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc+0.10+1.28%
AKAOAchaogen Inc+0.17+1.57%
RETAReata Pharmaceutical...-0.55-2.22%
AKBAAkebia Therapeutics ...+0.20+1.33%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$330.7K
Annual profit (last year)-$116.4M
Net profit margin-35,205.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts